Late Breaking Abstract - Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia - The BESTCILIA randomized placebo-controlled trial

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningfagfællebedømt

Standard

Late Breaking Abstract - Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia - The BESTCILIA randomized placebo-controlled trial. / Kobbernagel, Helene; Buchvald, Frederik F.; Haarman, Eric G.; Casaulta, Carmen; Collins, Samuel A.; Hogg, Claire; Kuehni, Claudia E.; Lucas, Jane S.; Omran, Heymut; Quittner, Alexandra L.; Werner, Claudius; Rosthøj, Susanne; Sorensen, Anne L.; Nielsen, Kim G.

I: European Respiratory Journal, Bind 54, Nr. Supplement 63, RCT5102, 2019.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningfagfællebedømt

Harvard

Kobbernagel, H, Buchvald, FF, Haarman, EG, Casaulta, C, Collins, SA, Hogg, C, Kuehni, CE, Lucas, JS, Omran, H, Quittner, AL, Werner, C, Rosthøj, S, Sorensen, AL & Nielsen, KG 2019, 'Late Breaking Abstract - Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia - The BESTCILIA randomized placebo-controlled trial', European Respiratory Journal, bind 54, nr. Supplement 63, RCT5102. https://doi.org/10.1183/13993003.congress-2019.RCT5102

APA

Kobbernagel, H., Buchvald, F. F., Haarman, E. G., Casaulta, C., Collins, S. A., Hogg, C., Kuehni, C. E., Lucas, J. S., Omran, H., Quittner, A. L., Werner, C., Rosthøj, S., Sorensen, A. L., & Nielsen, K. G. (2019). Late Breaking Abstract - Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia - The BESTCILIA randomized placebo-controlled trial. European Respiratory Journal, 54(Supplement 63), [RCT5102]. https://doi.org/10.1183/13993003.congress-2019.RCT5102

Vancouver

Kobbernagel H, Buchvald FF, Haarman EG, Casaulta C, Collins SA, Hogg C o.a. Late Breaking Abstract - Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia - The BESTCILIA randomized placebo-controlled trial. European Respiratory Journal. 2019;54(Supplement 63). RCT5102. https://doi.org/10.1183/13993003.congress-2019.RCT5102

Author

Kobbernagel, Helene ; Buchvald, Frederik F. ; Haarman, Eric G. ; Casaulta, Carmen ; Collins, Samuel A. ; Hogg, Claire ; Kuehni, Claudia E. ; Lucas, Jane S. ; Omran, Heymut ; Quittner, Alexandra L. ; Werner, Claudius ; Rosthøj, Susanne ; Sorensen, Anne L. ; Nielsen, Kim G. / Late Breaking Abstract - Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia - The BESTCILIA randomized placebo-controlled trial. I: European Respiratory Journal. 2019 ; Bind 54, Nr. Supplement 63.

Bibtex

@article{bee6bbbd72934e519ce485751b4a69d5,
title = "Late Breaking Abstract - Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia - The BESTCILIA randomized placebo-controlled trial",
keywords = "Orphan diseases, RCT (Randomized Controlled Trial), Exacerbation",
author = "Helene Kobbernagel and Buchvald, {Frederik F.} and Haarman, {Eric G.} and Carmen Casaulta and Collins, {Samuel A.} and Claire Hogg and Kuehni, {Claudia E.} and Lucas, {Jane S.} and Heymut Omran and Quittner, {Alexandra L.} and Claudius Werner and Susanne Rosth{\o}j and Sorensen, {Anne L.} and Nielsen, {Kim G.}",
year = "2019",
doi = "10.1183/13993003.congress-2019.RCT5102",
language = "English",
volume = "54",
journal = "The European Respiratory Journal",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "Supplement 63",

}

RIS

TY - ABST

T1 - Late Breaking Abstract - Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia - The BESTCILIA randomized placebo-controlled trial

AU - Kobbernagel, Helene

AU - Buchvald, Frederik F.

AU - Haarman, Eric G.

AU - Casaulta, Carmen

AU - Collins, Samuel A.

AU - Hogg, Claire

AU - Kuehni, Claudia E.

AU - Lucas, Jane S.

AU - Omran, Heymut

AU - Quittner, Alexandra L.

AU - Werner, Claudius

AU - Rosthøj, Susanne

AU - Sorensen, Anne L.

AU - Nielsen, Kim G.

PY - 2019

Y1 - 2019

KW - Orphan diseases

KW - RCT (Randomized Controlled Trial)

KW - Exacerbation

U2 - 10.1183/13993003.congress-2019.RCT5102

DO - 10.1183/13993003.congress-2019.RCT5102

M3 - Conference abstract in journal

VL - 54

JO - The European Respiratory Journal

JF - The European Respiratory Journal

SN - 0903-1936

IS - Supplement 63

M1 - RCT5102

ER -

ID: 235340714